HBP.TO Headlines | HELIX BIOPHARM Stock - Yahoo! Canada Finance

Thu May 23, 2013 6:36PM EDT - Canadian Markets closed

TSX

0.74% TSX Ventures 0.00%

More On HBP.TO

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Headlines
Company Events
Market Pulse

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Analyst Opinion
Analyst Estimates

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Helix BioPharma Corp. (HBP.TO)

-Toronto

0.90 0.06(7.14%) 3:55PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Monday, 8 April, 2013

Helix BioPharma Corp. Announces L-DOS47 Scientific Poster to Be Presented at American Association for Cancer Research Annual Meeting in Washington, DCMarketwired (Mon Apr 8)

Thursday, 4 April, 2013

Helix Biopharma Corp. Initiates Enrollment for Third Cohort and Expansion of Centres in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47Marketwired (Thu Apr 4)

Monday, 18 March, 2013

Helix BioPharma Corp. Announces L-DOS47 Scientific Presentation to Be Made at BIT LifeScience's 5th International Congress of AntibodiesMarketwired (Mon Mar 18)

Monday, 11 March, 2013

Helix BioPharma Corp. Announces Q2 Fiscal 2013 ResultsMarketwired (Mon Mar 11)

Thursday, 7 March, 2013

Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry DateMarketwired (Thu Mar 7)

Monday, 25 February, 2013

Helix BioPharma Announces Director ResignationMarketwired (Mon Feb 25)

Thursday, 21 February, 2013

Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry DateMarketwired (Thu Feb 21)
Helix BioPharma Announces Appointment of DirectorMarketwired (Thu Feb 21)

Sunday, 10 February, 2013

Helix BioPharma Announces Director ResignationMarketwired (Sun Feb 10)

Friday, 25 January, 2013

Helix Announces Completion of the Sale of Its Rivex Pharma Division to PharmascienceMarketwired (Fri Jan 25)

Thursday, 24 January, 2013

Helix Announces Shareholder Approval for the Sale of Its Rivex Pharma Division to Pharmascience and Other Results of Its Annual General and Special MeetingMarketwired (Thu Jan 24)

Thursday, 20 December, 2012

Helix BioPharma Announces Appointment of DirectorMarketwired (Thu Dec 20)
Clinical Update: Helix BioPharma Corp. Completes Enrollment in First Cohort and Initiates Second Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47Marketwired (Thu Dec 20)

Monday, 17 December, 2012

Helix BioPharma Announces Director ResignationsMarketwired (Mon Dec 17)
Helix BioPharma Announces Director ResignationsMarketwired (Mon Dec 17)

Friday, 14 December, 2012

Helix BioPharma and Merck Terminate Material Transfer and License Option Agreement for Topical Interferon Alpha-2b Development ProgramMarketwired (Fri Dec 14)

Thursday, 23 August, 2012

Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry DateMarketwired (Thu Aug 23)

Thursday, 19 July, 2012

Helix BioPharma Corp. Announces Filing of Form 15F to Terminate SEC Reporting ObligationsMarketwired (Thu Jul 19)

Monday, 25 June, 2012

Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKTMarketwired (Mon Jun 25)

Thursday, 14 June, 2012

Helix BioPharma Corp. Announces Q3 2012 Results and Actions Taken by Its New BoardMarketwired (Thu Jun 14)

Older Headlines

Copyright © 2009 Yahoo! All rights reserved.

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.